(ADP-ribose) polymerase 1 and AMP-activated protein kinase mediate progressive dopaminergic neuronal degeneration in a mouse model of Parkinson's diseaseopen access
- Authors
- Kim, T. W.; Cho, H. M.; Choi, S. Y.; Suguira, Y.; Hayasaka, T.; Setou, M.; Koh, H. C.; Hwang, E. Mi; Park, J. Y.; Kang, S. J.; Kim, H. S.; Kim, H.; Sun, W.
- Issue Date
- Nov-2013
- Publisher
- NATURE PUBLISHING GROUP
- Keywords
- PARP-1; ATP; AMPK; 6-OHDA; Parkinson' s disease
- Citation
- CELL DEATH & DISEASE, v.4, pp.1 - 10
- Indexed
- SCIE
SCOPUS
- Journal Title
- CELL DEATH & DISEASE
- Volume
- 4
- Start Page
- 1
- End Page
- 10
- URI
- https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/161540
- DOI
- 10.1038/cddis.2013.447
- ISSN
- 2041-4889
- Abstract
- Genetic and epidemiologic evidence suggests that cellular energy homeostasis is critically associated with Parkinson's disease (PD) pathogenesis. Here we demonstrated that genetic deletion of Poly (ADP-ribose) polymerase 1 completely blocked 6-hydroxydopamine-induced dopaminergic neurodegeneration and related PD-like symptoms. Hyperactivation of PARP-1 depleted ATP pools in dopaminergic (DA) neurons, thereby activating AMP-activated protein kinase (AMPK). Further, blockade of AMPK activation by viral infection with dominant-negative AMPK strongly inhibited DA neuronal atrophy with moderate suppression of nuclear translocation of apoptosis-inhibiting factor (AIF), whereas overactivation of AMPK conversely strengthened the 6-OHDA-induced DA neuronal degeneration. Collectively, these results suggest that manipulation of PARP-1 and AMPK signaling is an effective therapeutic approach to prevent PD-related DA neurodegeneration.
- Files in This Item
-
- Appears in
Collections - 서울 의과대학 > 서울 약리학교실 > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/161540)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.